We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
-26.86%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
–
AUM
$19.4M
AUM Growth
-$7.26M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
11 quarters
Top 10 Avg Time Held
11 quarters
Top 20 Avg Time Held
11 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ABCL icon
1
AbCellera Biologics
ABCL
$4.06B
$17.4M 89.37%
3,773,530
– –
2020 Q4
11 quarters
CMPS icon
2
Compass Pathways
CMPS
$1.66B
$2.06M 10.63%
278,880
– –
2020 Q4
11 quarters

Similar funds

Founders Fund VII Management's Q3 2023 Portfolio in Review

As of Q3 2023, Founders Fund VII Management held 2 positions worth $19.4M, down 27% from $26.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. Founders Fund VII Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VII Management's ten largest holdings make up 100% of its $19.4M portfolio in Q3 2023.
  • Founders Fund VII Management opened 0 new positions and closed 0 in Q3 2023.
  • Founders Fund VII Management's portfolio value fell 27% quarter-over-quarter to $19.4M.

Based on Founders Fund VII Management's 13F filing for Q3 2023, filed 14 Nov 2023.